Investors Contact Payment Careers Research Request
Interpace Biosciences®, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Pharma Solutions
  • Support
  • Labs
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Payment
  • Careers
  • Research Request

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Presentations
  • Events

Interpace Diagnostics Announces Pricing of $13.7 Million Underwritten Public Offering of Common Stock and Common Warrants

Jun 16, 2017

Interpace Diagnostics Announces Agreement with Einstein Medical Center of Philadelphia

Jun 5, 2017

Interpace Diagnostics Announces Launch of Enhancement to Thyroid Testing Services

May 24, 2017

Interpace Diagnostics Group Reports First Quarter 2017 Financial Results, Business Progress and Recent Accomplishments

May 15, 2017

Interpace Diagnostics to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results on Monday May 15, 2017

May 12, 2017

Interpace Diagnostics Presents New Data on PancraGEN® at DDW

May 10, 2017

Interpace Diagnostics to Present New Data in Six Posters Related to PancraGEN™ at Upcoming Annual DDW International Meeting on May 6-9, 2017

May 1, 2017

Interpace Diagnostics to Present at RedChip's Global Online Growth Conference

Apr 24, 2017

Interpace Diagnostics Eliminates Long Term Secured Debt

Apr 20, 2017

Interpace Announces Coverage of ThyraMIR® with UnitedHealthcare

Apr 18, 2017
    • 1...
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    © 2023 Interpace Biosciences®, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap
    We Own Our Future Logo
    • Linkedin